Effects of an oral contraceptive containing chlormadinone and ethinylestradiol on acne-prone skin of women of different age groups: An open-label, single-centre, phase IV study

Clinical Drug Investigation

Volumn 28, Issue 11, 2008, Pages 703-711

  Kerscher, Martina ^a   Reuther, Tilmann ^a   Bayrhammer, Julia ^a   Schramm, Georg ^b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b GRÜNENTHAL GMBH   (Germany)

Author keywords

Acne; Ethinylestradiol chlormadinone, therapeutic use; Oral contraceptives, therapeutic use

Indexed keywords

CHLORMADINONE ACETATE PLUS ETHINYLESTRADIOL; SKIN LIPID;

ACNE; ACUTE SINUSITIS; ADULT; AGE DISTRIBUTION; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE PREDISPOSITION; DRUG EFFECT; FEMALE; HORMONAL CONTRACEPTION; HUMAN; INFECTION; MEDICAL PHOTOGRAPHY; OPEN STUDY; ORAL CONTRACEPTION; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; SCORING SYSTEM; SELF EVALUATION; SKIN WATER LOSS; STRATUM CORNEUM; VIRAL SINUSITIS;

ACNE VULGARIS; ADOLESCENT; ADULT; AGE FACTORS; ANDROGEN ANTAGONISTS; BODY WATER; CHLORMADINONE ACETATE; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, SYNTHETIC; ETHINYL ESTRADIOL; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; LIPID METABOLISM; PATIENT SATISFACTION; PROSPECTIVE STUDIES; SKIN; TREATMENT OUTCOME; WATER LOSS, INSENSIBLE; YOUNG ADULT;

EID: 53549100199     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200828110-00004     Document Type: Article

References (26)

1. Korting HC, Ponce-Pöschl E, Klövekorn W, et al. The influence of the regular use of a soap or an acidic syndet bar on pre-acne. Infection 1995 Mar-Apr; 23 (2): 89-93
2. Rzany B, Kahl C. Epidemiology of acne vulgaris [in German]. J Dtsch Dermatol Ges 2006 Jan; 4 (1): 8-9
3. Williams C, Layton AM. Persistent acne in women: implications for the patient and for therapy. Am J Clin Dermatol 2006; 7 (5): 281-90
4. Kerscher M, Reuther T, Schramm G. Chlormadinonacetat enthaltende Mikropille verbessert unreine Haut. Frauenarzt 2007; 48 (4): 373-8
5. Gollnick H, Albring M, Brill K. The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type [in French]. Ann Endocrinol (Paris) 1999 Sept; 60 (3): 157-66
6. Raudrant D, Rabe T. Progestogens with antiandrogenic properties. Drugs 2003; 63 (5): 463-92
7. Worret I, Arp W, Zahradnik HP, et al. Acne resolution rates: results of a single-blind, randomized, controlled parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon). Dermatology 2001; 203 (1): 38-44
8. Zahradnik HP, Goldberg J, Andreas JO. Efficacy and safety of the new antiandrogenic oral contraceptive Belara. Contraception 1998 Feb; 57: 103-9
9. Kerscher M. Dermatokosmetik. Darmstadt: Steinkopff, 2004
10. Rabe TJ. Contraception: update and trends. J Reproduktionsmed Endokrinol 2007; 4 (6): 337-57
11. Draelos ZD. Cosmeceuticals. Philadelphia (PA): Elsevier Saunders, 2005
12. Williams SC, Kemper M, Kraus D, et al. Cutaneous lipid content, hydration, and pH in the human face [abstract]. Ann Dermatol Venereol 2002; 129: 472 (A)
13. Kim MK, Choi SY, Byun HJ, et al. Comparison of sebum secretion, skin type, pH in humans with and without acne. Arch Dermatol Res 2006 Aug; 298 (3): 113-9
14. Perry AL, Lambert PA. Propionibacterium acnes. Lett Appl Microbiol 2006 May; 42 (3): 185-8
15. Plewig G, Kligman AM. Acne and rosacea. Berlin: Springer Verlag, 2000
16. Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol 2004 Sept-Oct; 22 (5): 360-6
17. Lawrence DM, Katz M, Robinson TWE, et al. Reduced sex hormone binding globulin and derived free testosterone levels in women with severe acne. Clin Endrocrinol 1981 Jul; 15 (1): 87-91
18. Neumann F, Schleusener A, Humpel M. Antiandrogene: Pharmakologische Grundlagen. Gynäkologe 1979; 12: 228-42
19. Bouchard P. Chlormadinone acetate (CMA) in oral contraception: a new opportunity. Eur J Contracept Reprod Health Care 2005; 10 Suppl. 1: 7-11
20. Schramm G, Steffens D. A 12-month evaluation of the CMA-containing oral contraceptive Belara: efficacy, tolerability and anti-androgenic properties. Contraception 2003 Apr; 67 (4): 305-12
21. Kuhl H. Chemie und Pharmakologie von Chlormadinonacetat In: Loch E-G, Schramm G, editors. Chlormadinonacetat bei Androgenisierungserscheinungen. Stuttgart: Schattauer, 1995: 1-12
22. Piérard-Franchimont C, Gaspard U, Lacante P, et al. A quantitative biometrological assessment of acne and hormonal evaluation in young women using a triphasic low-dose oral contraceptive containing gestodene. Eur J Contraception Repr Health Care 2000 Dec; 5 (4): 275-86
23. Youn SW, Park ES, Lee DH, et al. Does facial sebum excretion really affect the development of acne? Br J Dermatol 2005 Nov; 153 (5): 919-24
24. Zouboulis CC, Eady A, Philpott M, et al. What is the pathogenesis of acne? Exp Dermatol 2005 Feb; 14 (2): 143-52
25. Thune P, Nilsen T, Hanstad IK, et al. The water barrier function of the skin in relation to the water content of stratum corneum, pH and skin lipids: the effect of alkaline soap and syndet on dry skin in elderly, non-atopic patients. Acta Derm Venereol 1988; 68 (4): 277-83
26. Eisenbeiss C, Welzel J, Eichler W, et al. Influence of body water distribution on skin thickness: measurements using high-frequency ultrasound. Br J Dermatol 2001 May; 144 (5): 947-51